Global Generic Injectables Market 2022-2028
June 2022
71
About the Report
About the Report
Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. The global generic injectables market size is projected to grow by USD 49 billion from 2022 to 2028, registering a CAGR of 8.7 percent, according to a new report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global generic injectables market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the generic injectables industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, route of administration, application, and region. The global market for generic injectables can be segmented by product: large molecule, small molecule. Generic injectables market is further segmented by route of administration: intravenous (IV) generic injectables, intramuscular (IM) generic injectables, subcutaneous (SC) generic injectables, others. Based on application, the generic injectables market is segmented into: oncology, infectious diseases, cardiology, diabetes, immunology, others. On the basis of region, the generic injectables market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).
By product:
- large molecule
- small molecule
By route of administration:
- intravenous (IV) generic injectables
- intramuscular (IM) generic injectables
- subcutaneous (SC) generic injectables
- others
By application:
- oncology
- infectious diseases
- cardiology
- diabetes
- immunology
- others
By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
The global generic injectables market report offers detailed information on several market vendors, including AstraZeneca plc, Baxter International, Inc., Dr. Reddy's Laboratories Ltd., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals plc, Lupin Limited, Merck & Co., Inc., Mylan N.V., Pfizer, Inc, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global generic injectables market.
- To classify and forecast the global generic injectables market based on product, route of administration, application, region.
- To identify drivers and challenges for the global generic injectables market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global generic injectables market.
- To identify and analyze the profile of leading players operating in the global generic injectables market.
Why Choose This Report
- Gain a reliable outlook of the global generic injectables market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Products
Products
Generic Injectables,
Companies
AstraZeneca plc, Baxter International Inc., Dr. Reddy's Laboratories Ltd., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals plc, Lupin Limited, Merck & Co. Inc., Mylan N.V., Pfizer Inc
Table of Contents
Table of Contents
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
- Report description
- Objectives of the study
- Market segment
- Years considered for the report
- Currency
- Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
- Introduction
- Drivers
- Restraints
- Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
- Large molecule
- Small molecule
PART 6. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION
- Intravenous (IV) generic injectables
- Intramuscular (IM) generic injectables
- Subcutaneous (SC) generic injectables
- Others
PART 7. MARKET BREAKDOWN BY APPLICATION
- Oncology
- Infectious diseases
- Cardiology
- Diabetes
- Immunology
- Others
PART 8. MARKET BREAKDOWN BY REGION
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
PART 9. KEY COMPANIES
- AstraZeneca plc
- Baxter International, Inc.
- Dr. Reddy's Laboratories Ltd.
- Fresenius SE & Co. KGaA
- Hikma Pharmaceuticals plc
- Lupin Limited
- Merck & Co., Inc.
- Mylan N.V.
- Pfizer, Inc
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.